Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study

Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A. Buchan, Christiaan H. Righolt, Salaheddin M. Mahmud, Naveed Zafar Janjua, Mel Krajden, Gaston De Serres, Jeffrey C. Kwong the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators
doi: https://doi.org/10.1101/2022.04.13.22273825

Article Information

doi 
https://doi.org/10.1101/2022.04.13.22273825
History 
  • April 13, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sharifa Nasreen1,2,
  2. Yossi Febriani3,
  3. Héctor Alexander Velásquez García4,5,
  4. Geng Zhang6,
  5. Mina Tadrous2,7,8,
  6. Sarah A. Buchan1,2,9,10,
  7. Christiaan H. Righolt6,
  8. Salaheddin M. Mahmud6,
  9. Naveed Zafar Janjua4,5,11,
  10. Mel Krajden4,12,
  11. Gaston De Serres3,13,14,
  12. Jeffrey C. Kwong1,2,9,10,15,16,* and
  13. the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators
  1. 1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
  2. 2ICES, Toronto, Ontario, Canada
  3. 3Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada
  4. 4British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
  5. 5School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  6. 6Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
  7. 7Women’s College Hospital, Toronto, Ontario, Canada
  8. 8Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
  9. 9Public Health Ontario, Toronto, Ontario, Canada
  10. 10Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
  11. 11Centre for Health Evaluation and Outcome Sciences, St Paul’s Hospital, Vancouver, British Columbia, Canada
  12. 12Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
  13. 13Institut national de sante publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada
  14. 14Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada
  15. 15Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
  16. 16University Health Network, Toronto, Ontario, Canada
  1. ↵*Corresponding author : Jeffrey C. Kwong, Senior Scientist, ICES, G1 06, 2075 Bayview Avenue, Toronto, Ontario, Canada, M4N 3M5, jeff.kwong{at}utoronto.ca, Phone: (416) 480-4055 x1-7665 Fax: (416) 480-6048
Back to top
Posted April 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study
Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A. Buchan, Christiaan H. Righolt, Salaheddin M. Mahmud, Naveed Zafar Janjua, Mel Krajden, Gaston De Serres, Jeffrey C. Kwong
medRxiv 2022.04.13.22273825; doi: https://doi.org/10.1101/2022.04.13.22273825
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area